Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 4 × Hyperandrogenism × Cyproterone acetate, ethinyl estradiol drug combination × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Polycystic Ovary Syndrome 2 Menstruation Disturbances 1 Hyperandrogenism 1

Interventions

drospirenone and ethinyl estradiol combination 3 Ethinyl Estradiol 2 Topiramate 1 Metformin 1 Glycoprotein Hormones, alpha Subunit 1 Cyproterone acetate, ethinyl estradiol drug combination 1 Cyproterone Acetate 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02027337 2014-11-21

Hemocoagulation and Lipoperoxidation in Women Using Combined Oral Contraceptives, Correction by Antioxidants

Tyumen State Medical Academy

Phase 4 Unknown

Menstruation Disturbances, Polycystic Ovary Syndrome, Hyperandrogenism

Data powered by HemOnc (CC BY 4.0) Colophon ⚡